Glycated fibroblast growth factor-2 is quickly produced in vitro upon low-millimolar glucose treatment and detected in vivo in diabetic mice

Molecular Endocrinology

Volumn 20, Issue 11, 2006, Pages 2806-2818

  Facchiano, Francesco ^a,b   D'Arcangelo, Daniela ^b   Russo, Katia ^b   Fogliano, Vincenzo ^c   Mennella, Carmela ^c   Ragone, Raffaele ^d   Zambruno, Giovanna ^b   Carbone, Virginia ^e   Ribatti, Domenico ^f   Peschle, Cesare ^a   Capogrossi, Maurizio C ^b   Facchiano, Antonio ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e CNR   (Italy)

^f POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLUORESCENCE; GLYCATION; GLYCEMIC CONTROL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING;

ANIMALS; BINDING, COMPETITIVE; BLOOD GLUCOSE; CATTLE; CELLS, CULTURED; CHEMOKINES; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLUCOSE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; GROWTH SUBSTANCES; HUMANS; HYPERGLYCEMIA; MICE; MICE, INBRED NOD; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1;

EID: 33751540369     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0322     Document Type: Article

References (51)

1. Aronson D 2003 Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 21:3-12
2. Stehbens WE 1990 The epidemiological relationship of hypercholesterolemia, hypertension, diabetes mellitus and obesity to coronary heart disease and atherogenesis. J Clin Epidemiol 43:733-741
3. Chettab K, Zibara K, Belaiba SR, McGregor JL 2002 Acute hyperglycaemia induces changes in the transcription levels of 4 major genes in human endothelial cells: macroarrays-based expression analysis. Thromb Haemost 87:141-148
4. Laakso M 1999 Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48:937-942
5. Di Carli MF, Janisse J, Grunberger G, Ager J 2003 Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41:1387-1393
6. Shaw JE, Boulton AJ 1997 The pathogenesis of diabetic foot problems: an overview. Diabetes 46(Suppl 2):S58-S61
7. Wautier JL, Schmidt AM 2004 Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95:233-238
8. Jakus V, Rietbrock N 2004 Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 53:131-142
9. Aso Y, Inukai T, Tayama K, Takemura Y 2000 Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Acta Diabetol 37:87-92
10. Phillips SA, Thornalley PJ 1993 The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem 212:101-105
11. 13C] glucose model systems. J Agric Food Chem 49:800-803
12. Richard JP 1991 Kinetic parameters for the elimination reaction catalyzed by triosephosphate isomerase and an estimation of the reaction's physiological significance. Biochemistry 30:4581-4585
13. Glomb MA, Monnier VM 1995 Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270:10017-10026
14. Loidl-Stahlhofen A, Hannemann K, Spiteller G 1994 Generation of α-hydroxyaldehydic compounds in the course of lipid peroxidation. Biochim Biophys Acta 1213:140-148
15. Larger E, Marre M, Corvol P, Gasc JM 2004 Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. Diabetes 53:752-761
16. Facchiano F, Lentini A, Fogliano V, Mancarella S, Rossi C, Facchiano A, Capogrossi MC 2002 Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo. Am J Pathol 161:531-541
17. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A 1999 Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99:2239-2242
18. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM 1999 Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154:355-363
19. Ahmed MU, Thorpe SR, Baynes JW 1986 Identification of N ε-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889-4894
20. Fu MX, Knecht KJ, Thorpe SR, Baynes JW 1992 Role of oxygen in cross-linking and chemical modification of collagen by glucose. Diabetes 41(Suppl 2):42-48
21. Coussons PJ, Jacoby J, McKay A, Kelly SM, Price NC, Hunt JV 1997 Glucose modification of human serum albumin: a structural study. Free Radic Biol Med 22:1217-1227
22. Facchiano F, Libondi T, Stiuso P, Esposito C, Ragone R, Colonna G 1996 Effect of galactose on α-crystallin. Ophthalmic Res 28(Suppl 1):97-100
23. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, Baynes JW 1993 Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463-2469
24. Lyons TJ, Silvestri G, Dunn JA, Dyer DG, Baynes JW 1991 Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes 40:1010-1015
25. Aronson D, Rayfield EJ 2002 How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 1:1
26. Berg TJ, Clausen JT, Torjesen PA, Dahl-Jorgensen K, Bangstad HJ, Hanssen KF 1998 The advanced glycation end product Nε-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes. Diabetes Care 21:1997-2002
27. Ruderman NB, Williamson JR, Brownlee M 1992 Glucose and diabetic vascular disease. FASEB J 6:2905-2914
28. Schleicher ED, Wagner E, Nerlich AG 1997 Increased accumulation of the glycoxidation product Nε-(carboxymethyl) lysine in human tissues in diabetes and aging. J Clin Invest 99:457-468
29. Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, Cooper ME 1997 Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 40:619-628
30. Vlassara H, Bucala R, Striker L 1994 Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151
31. Makita Z, Vlassara H, Cerami A, Bucala R 1992 Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138
32. Brownlee M, Cerami A, Vlassara H 1988 Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321
33. Yeboah FK, Alli I, Yaylayan VA, Yasuo K, Chowdhury SF, Purisima EO 2004 Effect of limited solid-state glycation on the conformation of lysozyme by ESI-MSMS peptide mapping and molecular modeling. Bioconjug Chem 15:27-34
34. Winlove CP, Parker KH, Avery NC, Bailey AJ 1996 Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties. Diabetologia 39:1131-1139
35. Rosenthal NR, Barrett EJ 1985 An assessment of insulin action in hyperosmolar hyperglycemic nonketotic diabetic patients. J Clin Endocrinol Metab 60:607-610
36. Sun Y, Hayakawa S, Izumori K 2004 Modification of ovalbumin with a rare ketohexose through the Maillard reaction: effect on protein structure and gel properties. J Agric Food Chem 52:1293-1299
37. Minetti M, Pietraforte D, Carbone V, Salzano AM, Scorza G, Marino G 2000 Scavenging of peroxynitrite by oxyhemoglobin and identification of modified globin residues. Biochemistry 39:6689-6697
38. Burgermeister J, Paper DH, Vogl H, Linhardt RJ, Franz G 2002 LaPSvS1, a (1→3)-β-galactan sulfate and its effect on angiogenesis in vivo and in vitro. Carbohydr Res 337:1459-1466
39. Facchiano A, Russo K, Facchiano AM, De Marchis F, Facchiano F, Ribatti D, Aguzzi MS, Capogrossi MC 2003 Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties. J Biol Chem 278:8751-8760
40. Perollet C, Han ZC, Savona C, Caen JP, Bikfalvi A 1998 Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood 91:3289-3299
41. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M 2003 Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9:294-299
42. Russo K, Ragone R, Facchiano AM, Capogrossi MC, Facchiano A 2002 Platelet-derived growth factor-BB and basic fibroblast growth factor directly interact in vitro with high affinity. J Biol Chem 277:1284-1291
43. Goretzki L, Burg MA, Grako KA, Stallcup WB 1999 High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J Biol Chem 274:16831-16837
44. Bailly S, Brand C, Chambaz EM, Feige JJ 1997 Analysis of small latent transforming growth factor-β complex formation and dissociation by surface plasmon resonance. Absence of direct interaction with thrombospondins. J Biol Chem 272:16329-16334
45. Herzog A, Szegedi C, Jona I, Herberg FW, Varsanyi M 2000 Surface plasmon resonance studies prove the interaction of skeletal muscle sarcoplasmic reticular Ca(2+) release channel/ryanodine receptor with calsequestrin. FEBS Lett 472:73-77
46. 2+-binding protein. Biochemistry 36:1295-1305
47. D'Arcangelo D, Facchiano F, Barlucchi LM, Melillo G, Illi B, Testolin L, Gaetano C, Capogrossi MC 2000 Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. Circ Res 86:312-318
48. De Marchis F, Ribatti D, Giampietri C, Lentini A, Faraone D, Scoccianti M, Capogrossi MC, Facchiano A 2002 Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its α receptor. Blood 99:2045-2053
49. McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA 2001 Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 276:33964-33968
50. Ribatti D, Gualandris A, Bastaki M, Vacca A, Iurlaro M, Roncali L, Presta M 1997 New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J Vasc Res 34:455-463
51. Facchiano F, Benfenati F, Valtorta F, Luini A 1993 Covalent modification of synapsin I by a tetanus toxin-activated transglutaminase. J Biol Chem 268:4588-4591